Why Natco Pharma share zoomed 20% today
Khyati Shah04 Jun, 2021Business
Share of Natco Pharma rose 20 per cent to hit a fresh 52-week high of Rs 1188.95 in early tradeafter the Drug Controller General of India (DCGI) gave its nod to the firm start manufacturing antifungal anti-fungal drug Amphotericin B liposomal injection. Its demand has increased in the wake of a surge in black fungus infections. Four other firms Alembic Pharmaceuticals, Emcure Pharmaceuticals, Gufic Biosciences and Lyca Pharmaceuticals have also received DCGI's permission to produce the injection.
Related Bookmarks
- furniture removals sydney to albury
- Registration Renewals
- Plans on to up production of 3 key vaccines: Top official
- Decor La Rouge - 15 Best Indoor Plants & Importance of Plants In Your Home - Interior Design Agency
- Tips for Choosing the Best Home Health Care Facility in Houston
- Web Design Palm Springs
- US Pharma Firm HDT Bio Begins Phase III Trial Of Covid Vaccine In India
- Accompagnement Dirigeant D'entreprise
- Virtual Business Lebanon
- Glenmark arm, Emcure, 3 Other Pharma Cos. Line Up Rs 7,000-cr IPOs
Recent Profiles
Gk688
Hope Welfare Trust
Clouders Chartered Accountants
Luxury Sober Living Kona
Cjc-1295 With Dac Qrp Nutrition 2mg
Terkelsen Ewing
Cade Sutherland
Vj88
Allen James
Noonan Crosby